Sana Biotechnology Statistics
Total Valuation
SANA has a market cap or net worth of $564.87 million. The enterprise value is $461.95 million.
Important Dates
The last earnings date was Friday, November 8, 2024, before market open.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SANA has 223.27 million shares outstanding. The number of shares has increased by 14.69% in one year.
Current Share Class | 223.27M |
Shares Outstanding | 223.27M |
Shares Change (YoY) | +14.69% |
Shares Change (QoQ) | +0.41% |
Owned by Insiders (%) | 9.63% |
Owned by Institutions (%) | 57.89% |
Float | 130.91M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.93 |
P/TBV Ratio | 6.10 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.33.
Current Ratio | 4.47 |
Quick Ratio | 4.23 |
Debt / Equity | 0.33 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -92.90% and return on invested capital (ROIC) is -43.58%.
Return on Equity (ROE) | -92.90% |
Return on Assets (ROA) | -31.15% |
Return on Capital (ROIC) | -43.58% |
Revenue Per Employee | n/a |
Profits Per Employee | -$932,338 |
Employee Count | 328 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.76% in the last 52 weeks. The beta is 1.44, so SANA's price volatility has been higher than the market average.
Beta (5Y) | 1.44 |
52-Week Price Change | -39.76% |
50-Day Moving Average | 3.77 |
200-Day Moving Average | 6.44 |
Relative Strength Index (RSI) | 28.64 |
Average Volume (20 Days) | 1,690,212 |
Short Selling Information
The latest short interest is 34.28 million, so 15.36% of the outstanding shares have been sold short.
Short Interest | 34.28M |
Short Previous Month | 33.28M |
Short % of Shares Out | 15.36% |
Short % of Float | 26.19% |
Short Ratio (days to cover) | 32.61 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -296.76M |
Pretax Income | -244.90M |
Net Income | -305.81M |
EBITDA | -273.80M |
EBIT | -296.76M |
Earnings Per Share (EPS) | -$1.38 |
Full Income Statement Balance Sheet
The company has $199.01 million in cash and $96.08 million in debt, giving a net cash position of $102.92 million or $0.46 per share.
Cash & Cash Equivalents | 199.01M |
Total Debt | 96.08M |
Net Cash | 102.92M |
Net Cash Per Share | $0.46 |
Equity (Book Value) | 292.48M |
Book Value Per Share | 1.31 |
Working Capital | 163.15M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$227.95 million and capital expenditures -$47.04 million, giving a free cash flow of -$274.99 million.
Operating Cash Flow | -227.95M |
Capital Expenditures | -47.04M |
Free Cash Flow | -274.99M |
FCF Per Share | -$1.23 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |